Back to List View Graph View

Acute myeloid leukemia

Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy arising from the clonal expansion of myeloid precursor cells with impaired differentiation and uncontrolled proliferation.

Where the papers sit

9 papers from the last 6 months study acute myeloid leukemia directly · updated from PubMed 11 Nov 2026

Study type 0 clinical trials · 5 observational · 1 human data · 2 preclinical · 1 unclassified

Themes one subject

Those 9 are all about one subject.

  • AML Biology and Clinical Care

    AML research spans targeted CAR-T design, HSPC lineage regulation, secondary disease, treatment complications, relapse detection, and survivorship risk. Clinical work focuses on induction outcomes, infections, cardiometabolic comorbidity, catheter choice, and CNS relapse during FLT3-targeted therapy. Biological studies examine epigenetic regulators and gut-microbiota-derived hyodeoxycholic acid, while transcriptomic risk models support prognosis. The set is broad and exploratory, with no single therapeutic direction or recurring mechanism.

    9 papers

Papers

The 9 papers from the last 6 months that study acute myeloid leukemia directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

AML Biology and Clinical Care (9)
  1. Synthetic Notch CD123 and CLL1 chimeric antigen receptor T-cells (CAR-T) target acute myeloid leukemia and reduce off-tumor effects associated with CLL1 CAR-T cells. Molecular biomedicine · 16 Oct 2026 PMID 42886311
  2. Single-cell CRISPR screen maps epigenetic regulators of lineage specification and malignancies in human HSPCs. Cell stem cell · 13 Oct 2026 PMID 42869019
  3. Acute myeloid leukemia arising in treated chronic lymphocytic leukemia/small lymphocytic lymphoma: a challenge in analysis of lineage relationship. Journal of hematopathology · 19 Sept 2026 PMID 42762392
  4. Gut microbiota modulates hyodeoxycholic acid to inhibit leukemia development. Clinical science (London, England : 1979) · 15 Sept 2026 PMID 42742127
  5. Catheter-related complications in AML remission induction chemotherapy: a retrospective comparison of PICCs and CICCs. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 28 Aug 2026 PMID 42665709
  6. Early Induction Outcomes in Acute Myeloid Leukemia: Impact of Clinical Status, Infectious Complications, Cardiometabolic Comorbidities, and Diagnostic Features in a Cohort Study. La Clinica terapeutica · 28 Aug 2026 PMID 42664133
  7. Flow cytometric detection of isolated central nervous system relapse in acute myeloid leukemia under FLT3-targeted therapy. Journal of hematopathology · 24 Aug 2026 PMID 42635869
  8. CPSM: An R Package for Cancer Patient Survival Risk Model Using Transcriptomics and Clinical Data. GigaScience · 3 Jun 2026 PMID 42233233
  9. Real-World Risk of Myelodysplastic Syndrome/Acute Myeloid Leukemia and Other Second Primary Malignancies in Patients with Epithelial Ovarian Cancer Treated with Niraparib Maintenance Therapy: Results from a Postauthorization Safety Study. Advances in therapy · 20 May 2026 PMID 42159951

By study type

Observational studies and case reports (5)
  1. Acute myeloid leukemia arising in treated chronic lymphocytic leukemia/small lymphocytic lymphoma: a challenge in analysis of lineage relationship. Journal of hematopathology · 19 Sept 2026 PMID 42762392
  2. Catheter-related complications in AML remission induction chemotherapy: a retrospective comparison of PICCs and CICCs. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 28 Aug 2026 PMID 42665709
  3. Early Induction Outcomes in Acute Myeloid Leukemia: Impact of Clinical Status, Infectious Complications, Cardiometabolic Comorbidities, and Diagnostic Features in a Cohort Study. La Clinica terapeutica · 28 Aug 2026 PMID 42664133
  4. Flow cytometric detection of isolated central nervous system relapse in acute myeloid leukemia under FLT3-targeted therapy. Journal of hematopathology · 24 Aug 2026 PMID 42635869
  5. Real-World Risk of Myelodysplastic Syndrome/Acute Myeloid Leukemia and Other Second Primary Malignancies in Patients with Epithelial Ovarian Cancer Treated with Niraparib Maintenance Therapy: Results from a Postauthorization Safety Study. Advances in therapy · 20 May 2026 PMID 42159951
Human data, design not indexed (1)
  1. Single-cell CRISPR screen maps epigenetic regulators of lineage specification and malignancies in human HSPCs. Cell stem cell · 13 Oct 2026 PMID 42869019
Preclinical: animal, cell and lab studies (2)
  1. Synthetic Notch CD123 and CLL1 chimeric antigen receptor T-cells (CAR-T) target acute myeloid leukemia and reduce off-tumor effects associated with CLL1 CAR-T cells. Molecular biomedicine · 16 Oct 2026 PMID 42886311
  2. Gut microbiota modulates hyodeoxycholic acid to inhibit leukemia development. Clinical science (London, England : 1979) · 15 Sept 2026 PMID 42742127
Unclassified: not yet indexed with MeSH (1)
  1. CPSM: An R Package for Cancer Patient Survival Risk Model Using Transcriptomics and Clinical Data. GigaScience · 3 Jun 2026 PMID 42233233